CDK4 and interstitial lung disease: When looking at the pneumotox.com (last accessed April 2, 2024), a standard reference for ILD, the statement “pneumonitis/ILD” is reported for Palbociclib and Abemaciclib, whereas a general reference to the FDA warning on CDK4/6 inhibitors as a class is mentioned for Ribociclib.